glp 1 vs metformin Clinical Focus on GLP-1 Agonists in Type 2 Diabetes Mellitus Type 2 Diabetes Medications: Metformin,
Description
Rebound weight gain is possible after stopping treatment, but tapering off of the medication and maintaining your improved diet and exercise routine can significantly alleviate this risk
C., Hennig, G
Tirzepatide, contains tirzepatide, a dual GIP/GLP-1 receptor agonist
Protein kinase A mediates glucagon-like peptide 1-induced nitric oxide production and muscle microvascular recruitment
This is attributed to the growing prevalence of type-2 diabetes and the growing number of clinical trials and research for treatment propelled the market
Treatment allocation was blinded to patient and investigators
